Send Inquiry

Request To Call Back

VOTRIENT 400MGTAB

Name: VOTRIENT 400MGTAB
Brand: ONCOTRUST
Price: 15800.0 INR
Availability: InStock

Price 15800.0 INR/ Piece

Get a Price/Quote

MOQ : 1 Piece

VOTRIENT 400MGTAB Specification

Salt Composition
Pazopanib Hydrochloride 400mg

Indication
Treatment of advanced renal cell carcinoma and advanced soft tissue sarcoma

Dosage Form
Tablet

Feature
Tyrosine kinase inhibitor; oral targeted therapy

Ingredients
Each film-coated tablet contains Pazopanib (as hydrochloride) 400 mg and excipients

Application
Oral administration for oncology use

Temperature Needed For Fermentation
28 Celsius (oC)

Physical Color/Texture
Pink, white to off-white film-coated oval tablet

Storage Instructions
Store below 30C, protect from moisture

Shelf Life
24 Hours

Manufacturing License Number
As per manufacturer's details

Route of Administration
Oral

Packaging Type
Blister pack

Warning
To be sold by retail on the prescription of an Oncologist only

ATC Code
L01XE11

Packaging Size
30 tablets per box

Prescription Required
Yes

Pregnancy Category
D (Positive evidence of risk)

Common Side Effects
Diarrhea, hypertension, hair color changes, nausea, fatigue

Contraindication
Severe hepatic impairment, hypersensitivity to Pazopanib

Marketed By
GlaxoSmithKline

VOTRIENT 400MGTAB Trade Information

Minimum Order Quantity
1 Piece

Delivery Time
24 Hours

About VOTRIENT 400MGTAB

VOTRIENT 400 mg Tablet contains Pazopanib, a targeted anticancer medication used in the treatment of certain types of cancers. It works by inhibiting multiple tyrosine kinases involved in tumor growth and angiogenesis, thereby slowing the progression of cancer cells.

This medicine is widely prescribed for the treatment of advanced renal cell carcinoma (kidney cancer) and advanced soft tissue sarcoma in adult patients. VOTRIENT helps restrict the blood supply to cancer cells, preventing their growth and spread.

Key Benefits:

Targeted therapy for specific cancers
Helps slow tumor growth and spread
Effective in advanced kidney cancer and soft tissue sarcoma
Oral tablet for convenient administration

Product Details:

Brand Name: VOTRIENT
Strength: 400 mg
Dosage Form: Tablet
Active Ingredient: Pazopanib
Packaging: Bottle / Strip (as available)
Usage/Application: Oncology / Cancer Treatment

Directions for Use:

To be taken strictly as prescribed by an oncologist. Usually taken on an empty stomach (at least 1 hour before or 2 hours after food).

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Safety Information:

Prescription drug use under medical supervision only
Not recommended during pregnancy or breastfeeding
Regular monitoring of liver function may be required

Effective Targeted Therapy for Cancer

VOTRIENT tablets provide an advanced option for patients battling advanced renal cell carcinoma and soft tissue sarcoma. As a tyrosine kinase inhibitor, VOTRIENT targets specific pathways involved in cancer growth. This targeted approach aims to help control disease progression, offering patients and oncologists a valuable treatment alternative with proven clinical efficacy.

Convenient Oral Administration

Designed for oral use, VOTRIENT 400MG offers a non-invasive way for patients to manage their condition. Each tablet is film-coated and should be swallowed whole, making daily treatment straightforward. The 30-tablet blister pack ensures convenient and secure storage, aligning with the prescribed dosage regimen recommended by oncologists.

FAQ's of VOTRIENT 400MGTAB:

Q: How should VOTRIENT 400MG tablets be taken?

A: VOTRIENT tablets must be taken orally, once daily as directed by your oncologist. Swallow the tablet whole with water, without crushing or chewing. Always take the medication at least one hour before or two hours after a meal to ensure proper absorption.

Q: What medical conditions is VOTRIENT indicated for?

A: VOTRIENT is indicated for the treatment of adults with advanced renal cell carcinoma and advanced soft tissue sarcoma, as prescribed by an oncologist.

Q: When should VOTRIENT not be used?

A: Do not use VOTRIENT if you have severe hepatic impairment or are hypersensitive to Pazopanib or any of its ingredients. Consult your doctor regarding all contraindications before starting therapy.

Q: Where should I store VOTRIENT tablets?

A: Store VOTRIENT below 30C, away from moisture and direct sunlight. Keep the tablets in their original blister pack until use to maintain their quality and effectiveness.

Q: What are the most common side effects of VOTRIENT?

A: Common side effects include diarrhea, hypertension, hair color changes, nausea, and fatigue. Notify your oncologist if you experience any persistent or severe symptoms.

Q: What are the benefits of using VOTRIENT?

A: VOTRIENT's targeted action as a tyrosine kinase inhibitor helps slow the growth and spread of certain cancers, providing a clinically effective option for advanced cases that may not respond to standard therapies.

Q: Is a prescription required for purchasing VOTRIENT?

A: Yes, VOTRIENT is a prescription medication and should be dispensed by retail only with a valid oncology prescription, in accordance with regulatory guidelines.

Tell us about your requirement